|
Falnidamol
- 品牌：MedKoo
- 產(chǎn)地：美國
- 貨號：205950
- cas：196612-93-8
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請
| 產(chǎn)地 | 美國 |
| 品牌 | MedKoo |
| 貨號 | 205950 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 200.0mg; 500.0mg; 1.0g; 2.0g; 5.0g; 10.0g; |
| CAS編號 | 196612-93-8 |
| 純度 | >98%% |
| 是否進口 | 是 |
中文名稱:N4-(3-氯-4-氟-苯基)-N6-(1-甲基-4-哌啶)嘧啶并5,4-d嘧啶-4,6-二胺
中文別名:N8-(3-氯-4-氟苯基)-N2-(1-甲基-4-哌啶基)嘧啶并[5,4-D]嘧啶-2,8-二胺
CAS No:196612-93-8
分子式:C18H19ClFN7
沸點:594°Cat760mmHg
閃光點:313.1°C
折射率:1.7
密度:1.427
用途:Potent, selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase (IC 50 = 3 nM). Displays > 1000-fold lower potency against ErbB2 (IC 50 = 3.4 μ M) and a range of other related tyrosine kinases (IC 50 > 10 μ M). Oral administration inhibits growth of established human x..
中文別名:N8-(3-氯-4-氟苯基)-N2-(1-甲基-4-哌啶基)嘧啶并[5,4-D]嘧啶-2,8-二胺
CAS No:196612-93-8
分子式:C18H19ClFN7
沸點:594°Cat760mmHg
閃光點:313.1°C
折射率:1.7
密度:1.427
用途:Potent, selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase (IC 50 = 3 nM). Displays > 1000-fold lower potency against ErbB2 (IC 50 = 3.4 μ M) and a range of other related tyrosine kinases (IC 50 > 10 μ M). Oral administration inhibits growth of established human x..
